Development and Testing of an Electronic Diabetes Diary Integrated With a Hospital Information System for Individuals With Type 2 Diabetes Mellitus: Protocol for a Mixed Methods Study

Author:

Skaria GeenaORCID,Reshmi BhageerathyORCID,K M SabuORCID,Shetty SahanaORCID,Lakshmi R VaniORCID

Abstract

Background Type 2 diabetes mellitus (T2DM) is one of the leading noncommunicable diseases that require diabetes self-management (DSM) practices. This study proposes to develop a customized mobile health (mHealth) app integrated with a hospital information system (HIS) to enable real-time, two-way transfer of information between the patient and physician. The captured information in the electronic health record will facilitate physicians to have a chronological account of the patient’s diabetes history and enable tweaking of the treatment. Objective The objectives of the study are (1) to develop the HIS-integrated Electronic Diabetes Diary (EDDy) per the end-user expectations at a tertiary care hospital in a south Indian state with a high prevalence of T2DM and (2) to evaluate and test adherence to EDDy in the management of T2DM. Methods The study will be carried out in 3 phases. Phase 1 involved in-depth interviews with primary end users to gather information regarding their expectations from the hospital-based EDDy. Phase 2 will use this information to develop a customized mHealth app using an iterative model of software development. Phase 3 will involve a pre- and posttest design; the developed app will be tested among consenting patients, where physicians will receive the patients’ data through the HIS-integrated mHealth app. The pre- and posttest values will be analyzed for adherence leading to improvement in patients’ self-management of blood glucose, user experience, glycemic control, and clinical utility. Results Phase 1 was completed on November 28, 2023. Phase 2 commenced in December 2023 and will end in May 2025. Phase 3 will follow afterward. Conclusions The proposed app will include a convenient and simple alert system that enables the patient to test glucose values at self-selected intervals, provide grading options to enter diabetic-related complications, enhance patients’ knowledge of tracking and managing the complications of diabetes, and help in maintaining the visual representation of glucose values and complications. The simplicity and usability of the modules are its novelty, which may motivate the patients to keep track of their glucose values and help them attain better health outcomes. Trial Registration Clinical Trial Registry India CTRI/2023/03/051077; http://tinyurl.com/4tau4ndb International Registered Report Identifier (IRRID) PRR1-10.2196/50732

Publisher

JMIR Publications Inc.

Subject

General Medicine

Reference14 articles.

1. SharmaNCGovernment survey found 11.8% prevalence of diabetes in IndiaMint201910102024-01-12https://www.livemint.com/science/health/government-survey-found-11-8-prevalence-of-diabetes-in-india-11570702665713.html

2. GaikwadLBapatSVDiabetes among senior citizens more prevalent in urban India: LASI reportDown To Earth20211132024-01-12http://tinyurl.com/4tz3ytnt

3. Research and MarketsIndia glucose monitoring devices market report 2020: historical data 2016-2019, base year of 2020, estimates for 2021 and forecasts 2022-2026Globe Newswire202011242024-01-12https://www.globenewswire.com/en/news-release/2020/11/24/2132509/28124/en/news

4. Digital health and diabetes: experience from India

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3